Circulation · 2013 · 313 citations · 16 references
MedicineCardiologySurgeryInterventional CardiologyOrthopedicsVascular SurgeryBalloon AngioplastyCoronary AngioplastyCritical Limb IschemiaEndovascular SurgeryLower Extremity RevascularizationPeripheral Arterial InterventionCritical Limb Ischemia InterventionCritical Limb Ischemia TreatmentCulprit Lesion RevascularizationLower Limb IschemiaPeripheral AngioplastyPeripheral Arterial Disease InterventionPeripheral Balloon AngioplastyTarget Lesion Revascularization
BACKGROUND: The 1-year restenosis rate after balloon angioplasty of long lesions in below-the-knee arteries may be as high as 70%. Our aim was to investigate the efficacy of a paclitaxel drug-eluting balloons versus conventional percutaneous transluminal angioplasty (PTA) for the reduction of restenosis in diabetic patients with critical limb ischemia undergoing endovascular intervention of below-the-knee arteries. METHODS AND RESULTS: The Drug-Eluting Balloon in Peripheral Intervention for below the knee angioplasty evaluation (DEBATE-BTK) is a randomized, open-label, single-center study comparing drug-eluting balloons and PTA. Inclusion criteria were diabetes mellitus, critical limb ischemia (Rutherford class 4 or higher), significant stenosis or occlusion >40 mm of at least 1 below-the-knee vessel with distal runoff, and life expectancy >1 year. Binary in-segment restenosis at a 1-year angiographic or ultrasonographic follow-up was the primary end point. Clinically driven target lesion revascularization, major amputation, and target vessel occlusion were the secondary end points. One hundred thirty-two patients with 158 infrapopliteal atherosclerotic lesions were enrolled. Mean length of the treated segments was 129±83 mm in the drug-eluting balloon group compared with 131±79 mm in the PTA group (P=0.7). Binary restenosis, assessed by angiography in >90% of patients, occurred in 20 of 74 lesions (27%) in the drug-eluting balloon group compared with 55 of 74 lesions (74%) in the PTA group (P<0.001); target lesion revascularization, in 12 (18%) versus 29 (43%; P=0.002); and target vessel occlusion, in 12 (17%) versus 41 (55%; P<0.001). Only 1 major amputation occurred, in the PTA group (P=0.9). CONCLUSIONS: Drug-eluting balloons compared with PTA strikingly reduce 1-year restenosis, target lesion revascularization, and target vessel occlusion in the treatment of below-the-knee lesions in diabetic patients with critical limb ischemia.
16
Inhibition of Restenosis in Femoropopliteal Arteries
Michael Werk, Sönke Langner, Bianka Reinkensmeier et al. · Circulation · 2008 · 507 citations · Full text
Medicine, Cardiology, Surgery +17
Dierk Scheinert, Konstantinos Katsanos, Thomas Zeller et al. · Journal of the American College of Cardiology · 2012 · 273 citations
Medicine, Cardiology, Surgery +17